Form 8-K - Current report:
SEC Accession No. 0001628280-25-004514
Filing Date
2025-02-10
Accepted
2025-02-10 07:02:11
Documents
15
Period of Report
2025-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K incy-20250210.htm   iXBRL 8-K 25139
2 EX-99.1 incy-q42024xexx991.htm EX-99.1 368551
6 incy-20220802xex99d1001a.jpg GRAPHIC 8537
  Complete submission text file 0001628280-25-004514.txt   560751

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT incy-20250210.xsd EX-101.SCH 1779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT incy-20250210_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT incy-20250210_pre.xml EX-101.PRE 12506
17 EXTRACTED XBRL INSTANCE DOCUMENT incy-20250210_htm.xml XML 2715
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Filer) CIK: 0000879169 (see all company filings)

EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12400 | Film No.: 25603621
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)